SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16840744
Source:
http://linkedlifedata.com/resource/pubmed/id/16840744
Search
Subject
(
69
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0036202
,
umls-concept:C0087111
,
umls-concept:C0205191
,
umls-concept:C0666743
,
umls-concept:C1314939
,
umls-concept:C2709248
pubmed:issue
7
pubmed:dateCreated
2006-9-21
pubmed:abstractText
Evidence suggests that tumor necrosis factor (TNF)-alpha plays an important role in the pathophysiology of sarcoidosis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16840744-16988163
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16840744-17461746
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/16840744-17675452
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9421642
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Peptidyl-Dipeptidase A
,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
,
http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1073-449X
pubmed:author
pubmed-author:AlberaCarloC
,
pubmed-author:BarnathanElliot SES
,
pubmed-author:BaughmanRobert PRP
,
pubmed-author:BrutscheMartinM
,
pubmed-author:CostabelUlrichU
,
pubmed-author:DavisGeraldG
,
pubmed-author:DonohueJames FJF
,
pubmed-author:DrentMarjoleinM
,
pubmed-author:FlavinSusanS
,
pubmed-author:JudsonMarc AMA
,
pubmed-author:KavuruManiM
,
pubmed-author:LoKim HungKH
,
pubmed-author:Müller-QuernheimJoachimJ
,
pubmed-author:OemarBarryB
,
pubmed-author:Sarcoidosis Investigators
,
pubmed-author:Schlenker-HercegRozsaR
,
pubmed-author:du BoisRolandR
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
174
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
795-802
pubmed:dateRevised
2007-10-5
pubmed:meshHeading
pubmed-meshheading:16840744-Adult
,
pubmed-meshheading:16840744-Antibodies, Monoclonal
,
pubmed-meshheading:16840744-Chronic Disease
,
pubmed-meshheading:16840744-Female
,
pubmed-meshheading:16840744-Humans
,
pubmed-meshheading:16840744-Infusions, Intravenous
,
pubmed-meshheading:16840744-Male
,
pubmed-meshheading:16840744-Middle Aged
,
pubmed-meshheading:16840744-Peptidyl-Dipeptidase A
,
pubmed-meshheading:16840744-Sarcoidosis, Pulmonary
,
pubmed-meshheading:16840744-Treatment Outcome
,
pubmed-meshheading:16840744-Tumor Necrosis Factor-alpha
,
pubmed-meshheading:16840744-Vital Capacity
pubmed:year
2006
pubmed:articleTitle
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
pubmed:affiliation
University of Cincinnati Medical Center, Cincinnati, OH 45267, USA. bob.baughman@uc.edu
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase II